Josep Font
Impact in
- Rheumatology top 0.02%
- Systemic Lupus Erythematosus Research
- Hematology top 0.2%
- Platelet Disorders and Treatments
Papers in
- Rheumatology 143
- Systemic Lupus Erythematosus Research 134
- Hematology 41
- Platelet Disorders and Treatments 32
- Co-authors
- Ricard CerveraM IngelmoManuel Ramos‐CasalsMario García‐CarrascoGerard EspinosaRonald A. AshersonMunther A. KhamashtaPilar Brito‐Zerón
- Journals
- Lupus (26 papers)Medicine (19 papers)Seminars in Arthritis and Rheumatism (14 papers)Autoimmunity Reviews (11 papers)Annals of the Rheumatic Diseases (10 papers)
- Partner nations
- SpainMexicoSouth Africa
In The Last Decade
Josep Font
200 papers receiving 11.4k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Rheumatology 7.8k
- Hematology 2.1k
- Nephrology 1.2k
- Hepatology 1.3k
- Immunology 3.0k
Countries citing papers authored by Josep Font
This map shows the geographic impact of Josep Font's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep Font with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep Font more than expected).
Fields of papers citing papers by Josep Font
This network shows the impact of papers produced by Josep Font. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep Font. The network helps show where Josep Font may publish in the future.
Co-authors
The 25 scholars most cited alongside Josep Font, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 19 | |
| 2 | 2006 | 232 | |
| 3 | 2006 | 14 | |
| 4 | 2006 | 124 | |
| 5 | 2005 | 117 | |
| 6 | 2005 | 24 | |
| 7 | 2005 | 113 | |
| 8 | Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period Hit paper breakdown → | 2003 | 987 |
| 9 | Raynaud's phenomenon in primary Sjögren's syndrome. Prevalence and clinical characteristics in a series of 320 patients. | 2002 | 46 |
| 10 | El tratamiento del fenómeno de Raynaud | 2000 | 2 |
| 11 | 2000 | 60 | |
| 12 | 1999 | 315 | |
| 13 | Virus y síndrome de Sjögren | 1999 | 4 |
| 14 | Anticardiolipin and antibeta2GPI antibodies in a large series of European patients with systemic lupus erythematosus | 1999 | 4 |
| 15 | 1998 | 369 | |
| 16 | 1998 | 84 | |
| 17 | 1998 | 222 | |
| 18 | Systemic Lupus Erythematosus Hit paper breakdown → | 1993 | 706 |
| 19 | Lupus eritematoso sistémico | 1991 | 0 |
| 20 | 1990 | 23 |
About Josep Font
Josep Font is a scholar working on Rheumatology, Hematology, Hepatology, Nephrology and Pathology and Forensic Medicine, having authored 206 papers that have together received 11.8k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (134 papers), Salivary Gland Disorders and Functions (39 papers), Platelet Disorders and Treatments (32 papers), Monoclonal and Polyclonal Antibodies Research (32 papers), Diabetes and associated disorders (30 papers), Systemic Sclerosis and Related Diseases (27 papers), Vasculitis and related conditions (19 papers) and T-cell and B-cell Immunology (16 papers). The work is most often cited by research in Rheumatology (7.8k citations), Hematology (2.1k citations), Nephrology (1.2k citations), Hepatology (1.3k citations) and Immunology (3.0k citations). Josep Font has collaborated with scholars based in Spain, Mexico and South Africa. Frequent co-authors include Ricard Cervera, M Ingelmo, Manuel Ramos‐Casals, Mario García‐Carrasco, Gerard Espinosa, Ronald A. Asherson, Munther A. Khamashta, Pilar Brito‐Zerón, Joan Carles Reverter and Gian Domenico Sebastiani. Their work appears in journals such as Lupus, Medicine, Seminars in Arthritis and Rheumatism, Autoimmunity Reviews and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.